Impact of antibiotics on immunotherapy response in lung cancer patients Source: International Congress 2019 – Treatment of lung cancer Year: 2019
How often do asthma patients claim prescribed therapy? Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS Year: 2017
The management of GERD in patients with advanced lung disease: drugs or surgery? Source: Annual Congress 2009 - The role of gastro-oesophageal reflux in advanced lung disease Year: 2009
Treating mesothelioma in 2021: what is the role of surgery and immunotherapy? Source: Virtual Congress 2021 – Hot news from the pleura Year: 2021
How are we going to treat IPF patients in the future? Source: Annual Congress 2013 –The future of IPF: current mysteries and challenges Year: 2013
Eosinophilia in lung cancer patients treated with immunotherapy Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019
Re-challenge of immunotherapy in a lung cancer patient Source: Virtual Congress 2021 – Lung cancer grand round Year: 2021
How to evaluate the immune status of lung cancer patients before immunotherapy Source: Breathe, 13 (4) 291; 10.1183/20734735.001917 Year: 2017
Impact of COPD on prognosis of lung cancer: the prespective of immunotherapy treatment Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021
Two therapy option in patients with uncontrolled asthma Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018
Sarcoidosis treatment and outcomes: what is most important to patients? Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018
Inhaled immunotherapy for lung cancer? Certainly possible. Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
Add-on omalizumab therapy for patients with severe persistent allergic (IgE-mediated) asthma: identifying which patients to treat and which patients respond Source: Eur Respir J 2006; 28: Suppl. 50, 440s Year: 2006
Can asthma patients cope with new treatment regimens in Ukraine? Source: Eur Respir J 2003; 22: Suppl. 45, 409s Year: 2003
Who should receive which biologic and why? Current and future approaches in severe asthma patients Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021
What is the scientific and clinical rationale? Triple therapy in COPD patients Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021
Who should treat lung cancer patients and where should they be treated? Source: Annual Congress 2009 - Fitness for radical therapy in lung cancer patients Year: 2009
What are the specificities of radiotherapy for elderly patients? Source: Annual Congress 2011 - Lung cancer management in the elderly Year: 2011
Specific immunotherapy efficiency along with the flixothide (fluticosan propionate) therapy for patients suffering from bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 385s Year: 2002